https://www.orthopaedicmanipulation.com/author/tahaabdelrahman/#google_vignette

Dr Abdelrahman Taha, السويس, Suez (2026)

30/03/2026

Walker et al [2019] reported that the screening process for cervical spine involvement in patients with SAPS was highly inconsistent or entirely absent, with 73.5% of RCTs either omitting the screening altogether or relying solely on symptom location.

- Reference:
Walker T, Salt E, Lynch G, et al Screening of the cervical spine in subacromial shoulder pain: a systematic review Shoulder Elbow 2019;11(4):305–315

30/03/2026

How much does a patient's mindset affect their physical recovery?

A recent case study delves into the critical role of maladaptive coping behaviors in a patient experiencing an acute lumbar lateral shift. The findings highlight a crucial intersection between physical rehabilitation and psychology, demonstrating that how a patient mentally processes and responds to pain significantly influences their level of disability.

This underscores a pressing need to move beyond standard protocols and invest in further research into individualized, biopsychosocial approaches. By specifically targeting cognitive and maladaptive pain behaviors, healthcare professionals can identify more effective, tailored strategies to manage acute pain-related disability and ultimately improve patient outcomes.

27/03/2026

Is the "SIJ Pain" Research We Rely On Built on a Shaky Foundation? 🦴

If you treat Sacroiliac Joint (SIJ) dysfunction, you know how tricky the differential diagnosis can be. But a recent review of 43 Randomized Controlled Trials (RCTs) reveals a glaring oversight in how we’re researching conservative management.
The findings are, frankly, a wake-up call for clinical research standards:

- 74.4% (32 trials) failed to screen the thoracolumbar spine at all before diagnosing SIJ pain.
- 20.9% (9 trials) performed only a partial screening.
- Only 4.7% (2 trials) conducted what could be considered a "reasonable" screening.

Why This Matters for Your Practice
We know that referred pain from the thoracolumbar junction can mimic SIJ symptoms perfectly. When research fails to "rule out" the spine, the internal validity of the study evaporates. If the participants didn't actually have SIJ dysfunction, how can we trust the efficacy of the conservative treatments being tested?

The Bottom Line
Poor screening practices + methodological weaknesses = unreliable evidence. We cannot improve patient outcomes if our gold-standard research is built on a flawed diagnostic process.

26/03/2026

Extremity pain isn’t always an extremity problem!

In musculoskeletal practice, we frequently diagnose extremity pain based on where it hurts and region-specific "special tests." But the evidence is clear: relying solely on local symptom location and tests with poor clinometric properties limits diagnostic accuracy and increases the risk of misdiagnosis. When we hyper-focus on the extremity, we risk overlooking a major contributor—the spine. Missing a spinal component often leads to suboptimal management strategies and frustrating plateaus in patient progress. To promote better, hypothesis-driven clinical decision-making, we need a structured approach to spinal screening for patients presenting with extremity pain. Here is what an effective spinal screening framework should prioritize:

1) Targeted Subjective Questioning: Dig deeper into the symptom behavior and history.
2) Spinal Motion Assessment: Evaluate regional mobility and symptom reproduction.
3) Neurological & Neurodynamic Testing: Rule in or out neural tissue involvement.
4) The Test-Treat-Retest Framework: Establish a comparable sign to immediately assess the effect of your intervention.

Incorporating routine spinal screening into extremity evaluations doesn't just improve our diagnostic accuracy—it elevates our entire standard of care and leads to more effective management of musculoskeletal pain.

25/03/2026

🧠 Are We Missing Hidden Neurological Involvement in Outpatient PT?

Relying solely on a patient's reported symptoms might mean overlooking crucial neurological factors—even in patients who don't have a formal Peripheral Neuropathic Pain (PNP) diagnosis.

A recent study looked into the prevalence of abnormal neurological findings in outpatient physical therapy, and the results for patients without a clinical PNP diagnosis are eye-opening:
- 50.6% exhibited abnormal reflexes
- 48.1% showed strength deficits
- 21% had sensory impairments
- 18.5% experienced symptom reproduction during Neurodynamic (ND) testing

The Key Takeaway:
Abnormal neurological findings are incredibly common in patients seeking outpatient PT, regardless of their PNP status. While ND test abnormalities are more strongly associated with a PNP diagnosis, standard clinical neurologic test abnormalities are prevalent across the board.

To refine our screening practices and elevate patient care, we must look beyond the primary diagnosis and ensure comprehensive neurological screening is a staple in our initial evaluations.

22/03/2026

Optimizing Obturator Nerve Neurodynamic Testing 🔬

Diagnosing obturator nerve injuries is challenging, and optimal Neurodynamic Testing (NDT) positions previously lacked biomechanical evidence. This cadaveric study measured intrapelvic nerve displacement and strain using fluoroscopy across three varying hip positions.

- The primary finding reveals that end-range hip abduction combined with hip extension or neutral significantly displaces the obturator nerve distally. Conversely, combining hip abduction with hip flexion failed to produce significant biomechanical displacement for optimal assessment.

- Clinical Implication 1: Clinicians can now confidently test the nerve using either hip extension or neutral positions, easily adapting to a patient's specific comfort level or available range of motion.

- Clinical Implication 2: These validated positions also support the clinical use of targeted neurodynamic mobilizations, such as nerve glides, to treat intrapelvic obturator neural injuries.

22/03/2026

Just came across this fantastic visual summary from the National Spine Network 2026 Annual Meeting, and I had to share some of the major highlights! 🧠🦴

It’s an incredible overview of where spine care, physiotherapy, and pain management are heading right now. Here are the main events and takeaways from the conference:

🌟 Honoring a Legacy
The event featured the Elaine Buchanan Founders Lecture, taking a moment to remember her lasting impact on the field.

🔬 Clinical Insights & Pain Science

- Radicular Pain (Prof. Annia Schmid): Brought new insights from "bench to bedside," emphasizing that nerve problems can still be present even if standard neurodynamic and neurological screens come back negative. Psycho-social factors play a huge role.

- Neurological Signs & Assessment (Dr. Tom Hayton): Addressed "when to worry" by breaking down underlying pathologies using the comprehensive V.I.N.D.I.C.A.T.E. framework (Vascular, Infective, Neoplastic, etc.) and advocating for better enquiry.

- Persistent Back Pain Myths (Prof. Cormac Ryan): Advocated for a public health approach to back pain, busting the massive myth that pain equals tissue damage. Key takeaway: Pain and injury are two different things!

🤝 Patient Care & The Future of Treatment

- The Role of Touch (Matt Low): Explored the future of physiotherapy and the shifting expectations around hands-on care ("You don't touch me anymore!").

- Balanced Treatment (Dr. Philipa Armstrong): Highlighted the need for a balanced view in pain clinics, blending interventional and biopsychosocial modalities to truly "listen, assess, & empower" patients.

- Leg Weakness Studies (Lucy Dove): Shared insights on the M.U.S.C.L.E.S. initiative, focusing on measuring and understanding sciatica and leg weakness.

🏥 System Shifts & Staff Wellbeing

- Burnout in Spine Care (Dr. Hannah Rogers): Took a hard look at the "hidden fractures" in healthcare—including burnout, bullying, and inequality—and practical steps for staff wellbeing.

- The Big Prevention Shift (Humera Sultan): Outlined how spine care aligns with the NHS 10-year plan, highlighting 3 Big Shifts: moving from hospital to community, analogue to digital, and sickness to prevention.

A truly spectacular day of learning and pushing the boundaries of how we treat and understand spinal health!

22/03/2026

🩺 Assessing Neck Pain: What the Evidence Says

The latest research on Neck Associated Disorders (NAD) reveals a surprising truth: many traditional clinical tests still lack "firmly established" validity. While tools like the Extension-Rotation and Spurling’s test are useful, clinicians must prioritize a thorough history and "red flag" screening to rule out serious pathology.

Objective measures, like the Neck Disability Index (NDI), are essential to capture the full picture of patient impairment beyond just pain levels. For blunt trauma, Clinical Prediction Rules remain the gold standard for safely clearing the spine without unnecessary imaging. Ultimately, we must balance clinical intuition with evidence-based tools to improve diagnostic accuracy and patient outcomes.

21/03/2026

🔍 The Pathoanatomic Debate: To Classify or Not to Classify?

In the world of physical therapy and rehabilitation, the use of clinical pathoanatomic-oriented classification systems remains a highly debated topic. Should we focus purely on movement and function, or do we need to identify the exact anatomical structure at fault?..,.. Let’s break down both sides of the literature:

🛑 Why Some Argue AGAINST It:
1- Clinical Necessity: Many argue that a physical therapist doesn't strictly need to identify a specific pathology to deliver effective care.
2- The Imaging Disconnect: We know there is often a poor correlation between imaging findings (like MRIs) and a patient's actual symptoms.
3- Fear-Avoidance: There is a valid concern that focusing too heavily on "tissue damage" or pathology can increase fear-avoidance behaviors and reinforce a "sick role" in patients.
4- Historical Data: Older pathoanatomic classification systems often lacked robust scientific backing, and some studies actively refuted their validity.

✅ Why It OUGHT to Be Regarded:
1- Patient Expectations: When patients seek care, they expect an anatomical explanation. Neglecting this expectation can negatively impact both patient satisfaction and treatment outcomes.
2- Empowerment over Fear: Evidence suggests fear-avoidance is driven by uncertainty, not necessarily the identification of pathology. Connecting the dots between anatomy, symptoms, and daily function can actually empower and motivate patients toward an active recovery.
3- Research & Efficacy: A pathoanatomic system is a necessary foundation for testing structural hypotheses. If a method (like McKenzie or orthopedic medicine) claims to influence a condition on a structural level, we need a way to classify and measure that.
4- Universal Communication: A pathoanatomic framework provides a universal language that is independent of specific rehab "schools of thought" and is highly meaningful to the broader medical community.
5- Emerging Data: While older systems lacked backing, recent data is increasingly supporting the validity of several modern pathoanatomic categories.

The Takeaway: Perhaps the sweet spot lies in integration—acknowledging the anatomical reality to validate the patient's experience and communicate with medical peers, while simultaneously using a biopsychosocial approach to prevent fear-avoidance.

21/03/2026

🧠 Pain Neuroscience: Redefining Fibrosis in Carpal Tunnel Syndrome

Historically, the connective tissue fibrosis causing Carpal Tunnel Syndrome (CTS) was considered strictly "non-inflammatory". However, transcriptomic profiling of patient tissues reveals significant genetic links between CTS, adaptive immunity, and the IGF-1 pathway. Individuals with high-risk genetic variants showed a distinct downregulation in T-cell immune mediators and IGF-1 regulators like IGFBP5.

This suggests that an intersection of chronic immune dysregulation and altered growth factor signaling ultimately drives the pathology.

18/03/2026

Rethinking Carpal Tunnel Syndrome (CTS): From Mechanical Wear to Immune Dysregulation 🔬

For years, the medical community has viewed the fibrosis of connective tissue in Carpal Tunnel Syndrome as strictly a "non-inflammatory" condition. The prevailing model pointed simply to increased pressure leading to impaired blood supply, nerve tethering, and tissue hyperplasia driven by growth factors like TGF-β. However, emerging research is challenging this long-standing model and revealing a much more complex, system-wide picture. Here is how our understanding of CTS pathophysiology is evolving:

💥 The Inflammatory Driver: Recent evidence suggests inflammation is a primary driver of pathological changes. Studies show elevated levels of CD3+ T cells within the subsynovial connective tissue (SSCT), alongside increased circulating cytokines (like CCL5 and CXCL8) and upregulated CD4+ memory T cells.

💥 A Genetic Shield: A recent Genome-Wide Association Study (GWAS) identified a protective genetic variant (the T allele rs62175241) at the DIRC3 locus on chromosome 2.

💥 The IGF Axis Connection: This protective allele increases the expression of IGFBP5, which helps sequester and regulate IGF-1 (a growth factor found at elevated levels in CTS patients). Crucially, the IGF axis isn't just about cell growth—it is deeply implicated in immune homeostasis and maintaining the balance between different T-cell subsets.

The Takeaway:
CTS is not just a localized, mechanical issue of "wear and tear." It represents a highly complex interplay between extracellular matrix (ECM) hyperplasia, genetic predisposition, and immune dysregulation. Understanding pathways like DIRC3/IGFBP5 could open new doors for how we view, and ultimately treat, fibrotic and nerve compression disorders.

18/03/2026

Is the line between neuropathic and non-neuropathic pain blurring? 🤔

A fascinating systematic review recently highlighted a significant finding regarding chronic pain conditions that we traditionally classify as non-neuropathic (such as fibromyalgia). By comparing the morphometric data of small nerve fibers in patients with these ICD-11 defined conditions against pain-free controls, the researchers uncovered morphological evidence of Small Nerve Fiber Pathology (SFP).

Key Takeaways for Clinical Practice:

- A Shift in Perspective: These findings implicate potential peripheral nervous system pathology in conditions we haven't typically viewed through a neuropathic lens.

- The Unknowns: While the morphological evidence is there, the actual clinical significance of these findings remains unclear and warrants further investigation.

As clinicians dedicated to managing complex pain presentations, this research challenges our traditional diagnostic boundaries. It reinforces the need to keep an open mind regarding peripheral nerve involvement during our differential diagnosis and clinical reasoning processes.

Dr Abdelrahman Taha

30/03/2026

30/03/2026

27/03/2026

26/03/2026

25/03/2026

22/03/2026

22/03/2026

22/03/2026

21/03/2026

21/03/2026

18/03/2026

18/03/2026

Address

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share

Category